Pfizer’s Kovid Pill PaxLovid has received WHO approval. All you need to know

The World Health Organization (WHO) said it “strongly recommends” Pfizer’s COVID-19 antiviral pill Paxlovid for patients…

‘Don’t give mollupiravir…’: WHO issues new guidelines on Merck’s COVID drug

The World Health Organization (WHO) has updated its life guidelines COVID-19 Medical Science Merck & Co.’s…

Phase III of COVID drug Movfor tests positive; 65% reduction in hospitalizations: Hetero

Drug firm Hetero today announced the positive results of Phase III trials of Movfor (molanupiravir), which…

Pfizer pill ‘PaxLovid’ becomes first US-authorized home COVID treatment

The pill has mild side effects and improved effectiveness, including a nearly 90% reduction in hospitalization…

Anti-Covid drug trial shows “strong efficacy”: AstraZeneca

AstraZeneca has already submitted an application to US regulators for approval of its COVID drug (File)…

video | “Pfizer’s COVID pill has the potential to be a game-changer”: Top Virologist to NDTV

“It gives us something where if you get infected, it’s something that could potentially put you…

Indian companies asked to bid for Molnupiravir deal

UnitAid, a global health initiative that works with partners to bring innovation to prevent, diagnose and…

Why Merck’s Covid pill is seen as great hope in the fight against the pandemic

As Merck & Co. is moving forward with an experimental pill that could play a key…

Firms gearing up to launch successful covid drug

Mumbai : Indian drug makers gearing up to play a significant role in the global market…

Merck’s pill designed to treat Kovid-19 succeeds in major study

The companies said on Friday that the pill reduced the risk of hospitalization or death by…